Physician profile
Fazal Ali
NPI 1023403854
$5,609.47
in general payments reported to CMS, 2019-2025
25 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $134 · 2021: $457 · 2022: $233 · 2023: $802 · 2024: $2,469 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,485 · Travel and Lodging: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,484.68 |
| Travel and Lodging | $1,045.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,457.80 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $880.28 | 2024-2025 | Barostim Neo System |
| Abiomed | $499.94 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $367.39 | 2019-2024 | Camzyos |
| Medtronic, INC. | $248.10 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $189.92 | 2021-2025 | Wainua, Farxiga |
| Inari Medical, INC. | $133.51 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $100.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $83.47 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.91 | 2022-2025 | Jardiance |
| Bridgebio Pharma, INC. | $74.70 | 2025 | Attruby |
| Pfizer INC. | $59.45 | 2019 | |
| Impulse Dynamics (USA) INC. | $55.73 | 2023-2025 | Optimizer, Optimizer |
| Scpharmaceuticals INC. | $55.11 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $49.47 | 2025 | Onpattro, Amvuttra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $43.78 | 2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $36.26 | 2019-2020 | |
| Briohealth Solutions, INC. | $34.70 | 2025 | Briovad |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.15 | 2021-2023 | Lifevest |
| Daxor Corporation | $28.80 | 2023 | Bva-100 |
| Astellas Pharma US INC | $25.36 | 2025 | Cresemba |
| Endotronix, INC. | $21.30 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Bayer Healthcare Pharmaceuticals INC. | $20.65 | 2025 | |
| Stryker Corporation | $18.28 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lantheus Medical Imaging, INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fazal Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.